As of Dec 07
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Corcept Therapeutics Inc have a median target of 8.50, with a high estimate of 12.00 and a low estimate of 5.00. The median estimate represents a +6.65% increase from the last price of 7.97.
The current consensus among 2 polled investment analysts is to Buy stock in Corcept Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.